Navigation Links
Gene fusion in lung cancer afflicting never-smokers may be target for therapy
Date:12/22/2011

December 22, 2011 Smoking is a well-known risk factor for lung cancer, but nearly 25% of all lung cancer patients have never smoked. In a study published online today in Genome Research (www.genome.org), researchers have identified a previously unknown gene fusion event that could explain a significant proportion of lung cancer cases in never-smokers, and might serve as a target for new therapies.

Recent strides have been made to identify gene mutation events driving cases of lung adenocarcinoma in never-smokers, but the underlying genetic events leading to these lung cancers still remain unknown in a large number of cases. In this report, using a combination of genome sequencing and RNA sequencing, a team of researchers in South Korea has characterized a previously unknown gene fusion event in a case of lung adenocarcinoma striking a 33-year-old Korean male with no history of smoking or cancer within his family.

The group sequenced and compared the genome of the patient's cancer and normal tissue (blood), but they found no mutations in known-cancer related genes, such as EGFR, KRAS, and EML4-ALK mutations, that were likely to explain this case. Delving deeper, they also sequenced RNA isolated from the cancer cells, which when analyzed, can reveal gene rearrangement events that are difficult to detect by genome sequencing and may be driving the cancer.

From the RNA sequencing analysis they built a list of candidate gene fusions, narrowing it down to a single gene fusion that could be a cancer-causing event. A genomic inversion event occurred on chromosome 10 in the cancer, fusing the KIF5B and RET genes. This fusion was particularly interesting because RET has been previously implicated in other gene fusion events known to drive thyroid cancers, and although it is normally expressed at low levels in the lung, chimeric RET in this patient is highly expressed. Furthermore, KIF5B contains a protein domain that is necessary for activation of the fusion gene.

They then confirmed that the KIF5B-RET fusion occurs in other lung cancer cases, finding two instances in twenty additional cases of lung cancer, indicating that this fusion event is not rare. The authors suggest that the KIF5B-RET fusion occurs in about 6% of all lung adenocarcinoma cases. The authors note that although further epidemiological studies are needed to accurately define the frequency of KIF5B-RET in lung cancers, they expect that the fusion gene may be a promising molecular target for treatment.

"We showed that genome sequencing technology could reveal a previously hidden cause of human cancer, which can be used as a therapeutic target for personal cancer therapy", said Dr. Jeong-Sun Seo, director of the Genomic Medicine Institute-Seoul National University, chairman of Macrogen Inc., and senior author of the study.


'/>"/>
Contact: Peggy Calicchia
calicchi@cshl.edu
Cold Spring Harbor Laboratory
Source:Eurekalert

Related medicine news :

1. University of Maryland finds restricting post-surgery blood transfusion is safe for some hip patients
2. Study Finds Fewer Blood Transfusions Needed After Hip Surgeries
3. New heart cells increase by 30 percent after stem cell infusion
4. Scientists Use Stem Cells for Blood Self-Transfusion
5. Pitt, Wake Forest team finds why stored transfusion blood may become less safe with age
6. Rhode Island Hospital fellow receives funding to support research in myocardial perfusion
7. 2-year results: Artificial disc a viable alternative to fusion for 2-level disc disease
8. Research provides insight into quality of stored blood used for transfusions
9. Can Platelet Transfusions Trigger Severe Reaction in Those With Peanut Allergies?
10. Halving the radiation dose in cardiac perfusion imaging is now feasible
11. Wrestlers Quick Weight Loss May Cause Mental Confusion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... , ... June 01, 2016 , ... A book about ... New Renaissance ” (published by Balboa Press AU) attempts to give readers the courage ... , β€œThe Divine has inspired and guided me throughout my life to learn ...
(Date:5/31/2016)... Hollywood, Fl (PRWEB) , ... May 31, 2016 ... ... the doors to its new Concussion Clinic serving South Florida. , The ... sports medicine, pediatric neurology, pediatric physical medicine and rehabilitation, pediatric neuropsychology and also ...
(Date:5/31/2016)... (PRWEB) , ... June 01, 2016 , ... ... β€œ Psoriasis and smoking: links and risks ”. , As corresponding author Professor ... on the relation between smoking habits and psoriasis. Smoking influences the onset and ...
(Date:5/31/2016)... ... ... adults often find themselves reaching for a cup of coffee, an energy drink, or even ... is a cup of Matcha green tea. Matcha is a premium green tea powder made ... early June to mid-July, when the leaves are the most tender. , Matcha ...
(Date:5/31/2016)... ... 2016 , ... Splashtop Inc., the worldwide leader in high performance cross-screen ... the leading provider of secure mobile remote access solution for Japan enterprises. ... access solution. Splashtop for CACHATTO will be available as an integrated add-on ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... , May 30, 2016 ... report "Healthcare Biometrics Market by Technology (Single-factor ... Multifactor, Multimodal), Application (Workforce Management), End User ... 2021", published by MarketsandMarkets, the market is ... 2021 from USD 1,182.6 Million by 2016, ...
(Date:5/30/2016)... 30, 2016 LifeScienceIndustryResearch.com adds ... research report with comprehensive information on the therapeutic ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ... key players involved in the therapeutic development for ...
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharma company focused on the highly lucrative ... a substantial pipeline of potential first-in-class or best-in-class ... are in development with strategic partners. HCM,s profitable ... fast-growing domestic market. We expect progress of the ...
Breaking Medicine Technology: